Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

Hiroyuki Narahara,Kazumasa Fujitani,Hiroya Takiuchi,Naotoshi Sugimoto,Kentaro Inoue,Noriya Uedo,Hideaki Tsukuma,Toshirnasa Tsujinaka,Hiroshi Furukawa,T. Taguchi

Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

2008

Hiroyuki Narahara
Kazumasa Fujitani
Hiroya Takiuchi
Naotoshi Sugimoto
Kentaro Inoue
Noriya Uedo
Hideaki Tsukuma
Toshirnasa Tsujinaka
Hiroshi Furukawa
T. Taguchi

Objectives: A phase II study of weekly paclitaxel combined with S-1, a novel oral fluoropyrimidine, was performed to evaluate the efficacy and tolerability in unresectable or metast

Keywords:

Stomach cancer
Pathology
Phases of clinical research
Cancer
Metastatic gastric cancer
Paclitaxel
Metastasis
Medicine
Tolerability
Regimen
combination chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations